Hemorheology, plasma protein composition and von Willebrand Factor in type I diabetic nephropathy

被引:0
|
作者
Zimmermann, J
Schramm, L
Wanner, C
Mulzer, E
Henrich, HA
Langer, R
Heidbreder, E
机构
[1] UNIV WURZBURG,DEPT MED,D-97080 WURZBURG,GERMANY
[2] UNIV WURZBURG,DEPT SURG,D-97080 WURZBURG,GERMANY
[3] UNIV WURZBURG,DIV EXPT SURG,D-97080 WURZBURG,GERMANY
关键词
nephropathy; hemorheology; blood viscosity; plasma viscosity; erythrocyte aggregation; erythrocyte deformability; fibrinogen; von Willebrand Factor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with IDDM, especially those with albuminuria are at high risk for macrovascular and microvascular complications. Besides the major classic risk factors altered hemorheology may also play a role. Plasma viscosity, erythrocyte aggregation and erythrocyte deformability are the major determinants of blood flow in the microcirculation. Therefore, these hemorheological parameters and plasma protein composition were evaluated in 58 IDDM-patients with none (N0), incipient (N1: albuminuria 30-300 mg/day) and overt clinical nephropathy (N2: albuminuria >300 mg/day). As an estimate of endothelial injury plasma levels of von Willebrand Factor (vWF) were investigated. Patients with incipient and clinical nephropathy exhibited increasing blood levels of fibrinogen (N0=2.47+/-0.09, N1=2.71+/-0.15, N2=3.49+/-0.24 g/l, p <0.001), alpha(2)-macroglobulin (N0=257+/-11, N1=251+/-21, N2=382+/-43 mg/100 ml, p <0.01) and haptoglobin (N0=174+/-16, N1=216+/-39, N2=278+/-36 mg/100 ml, p <0.05), whereas serum albumin concentration decreased (N0=5.1+/-0.1, N1=4.7+/-0.1, N2=4.1+/-0.2 g/100 ml, p <0.001). In the same patients erythrocyte aggregation (N0=10.0+/-0.4, N1=12.1+/-0.5, N2=12.9+/-0.6, p <0.001), plasma viscosity (N0=1.34+/-0.01, N1=1.38+/-0.02, N2=1.40+/-0.02 mPas, p <0.05) and erythrocyte rigidity (N0=0.05+/-0.01, N1=0.15+/-0.05, N2=0.09+/-0.02, p <0.05) were increased, predominantly in those with overt clinical nephropathy. Erythrocyte aggregation was positively correlated with plasma concentrations of fibrinogen (r=0.65, p <0.001) and alpha(2)-macroglobulin (r=0.35, p <0.05), but negatively with plasma albumin concentration (r=-0.49, p <0.001). Plasma viscosity was positively correlated with plasma concentrations of fibrinogen (r=0.46, p <0.001) and haptoglobin (r=0.46, p <0.001). Von Willebrand Factor levels were higher in patients with overt clinical nephropathy (N0=126+/-8, N1=136+/-12, N2=163+/-14%, p <0.09, P-N0-N2 <0.05). A significant correlation between vWF and the rheological determinants could not be detected. These data demonstrate that blood rheology is profoundly altered in patients with IDDM and nephropathy. Elevated levels of vWF may indicate endothelial damage, and changes in plasma viscosity as well as erythrocyte aggregability seem to be the result of altered plasma protein composition due to proteinuria. These abnormalities in hemorheology may be an aggravating factor promoting microvascular and macrovascular damage in patients with type I diabetes mellitus and nephropathy.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [21] Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
    Bauer, Alexander
    Friberg-Hietala, Sofia
    Smania, Giovanni
    Wolfsegger, Martin
    JOURNAL OF BLOOD MEDICINE, 2023, 14 : 399 - 411
  • [22] Structure and function of von Willebrand factor: the protein that is deficient and/or abnormal in inherited von Willebrand disease
    Hassan, Md Imtaiyaz
    Saxena, Aditya
    Ahmad, Faizan
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 11 - 22
  • [23] Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor
    Wu, YP
    vanBreugel, HHFI
    Lankhof, H
    Wise, RJ
    Handin, RI
    deGroot, PG
    Sixma, JJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (05) : 611 - 620
  • [24] Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
    Soares, Anna L.
    Kazmi, Rashid S.
    Borges, Michelle A.
    Rosario, Pedro W.
    Fernandes, Ana P.
    Sousa, Marinez O.
    Lwaleed, Bashir A.
    Carvalho, Maria G.
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (07) : 600 - 605
  • [25] Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
    Claes, J.
    Liesenborghs, L.
    Peetermans, M.
    Veloso, T. R.
    Missiakas, D.
    Schneewind, O.
    Mancini, S.
    Entenza, J. M.
    Hoylaerts, M. F.
    Heying, R.
    Verhamme, P.
    Vanassche, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 1009 - 1019
  • [26] ABO blood group genotypes, and loading of von Willebrand plasma von Willebrand factor levels factor with A and B antigens
    Morelli, Vania M.
    de Visser, Marieke C. H.
    van Tilburg, Nico H.
    Vos, Hans L.
    Eikenboom, Jeroen C. J.
    Rosendaal, Frits R.
    Bertina, Rogier M.
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (04) : 534 - 541
  • [27] Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
    Simon, D
    Bandinelli, E
    Roisenberg, I
    GENETICS AND MOLECULAR BIOLOGY, 2003, 26 (04) : 397 - 401
  • [28] Associations of multiple genetic variations with plasma levels of Von Willebrand Factor and clinical phenotype in Iranian patients with Von Willebrand disease type 1
    Zafarani, Alireza
    Tabibian, Shadi
    Barati, Mahmood
    Ghodratnia, Elnaz
    Safa, Majid
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
  • [29] Vascular endothelial markers, von willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease
    Hirano, T
    Ookubo, K
    Kashiwazaki, K
    Tajima, H
    Yoshino, G
    Adachi, M
    CLINICA CHIMICA ACTA, 2000, 299 (1-2) : 65 - 75
  • [30] PLASMA TOTAL HOMOCYSTEINE, LIPOPROTEIN (A) AND VON WILLEBRAND FACTOR LEVELS IN ASSESSMENT OF METABOLIC CONTROLS OF CHILDREN WITH TYPE I DIABETES MELLITUS
    Ertugrul, Sabahattin
    Sen, Yasar
    Yilmaz, Erdal
    Aydin, Mustafa
    Ustundag, Bilal
    NOBEL MEDICUS, 2014, 10 (03): : 75 - 80